series-c-plus
Stage
2
Investors
About
Lomond Therapeutics is a precision hematology biopharmaceutical company developing small molecule drugs that target resistant mutations in hematological and solid cancer malignancies.
Explore Lomond Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.